Antleron

@antleron

We merge the potential of cells, biomaterials, biologics, 3D printing & bioreactors to accelerate the engineering of medicinal products, devices & processes.

Vrijeme pridruživanja: lipanj 2019.

Tweetovi

Blokirali ste korisnika/cu @antleron

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @antleron

  1. 30. sij

    📄 Here's the intro post of our new blog series focusing on Advanced Therapy Medicinal Products (ATMPs): regulation, reimbursement, manufacturing, clinical studies, ... 🗂️ Read blogpost =>

    Poništi
  2. 15. sij

    Thank you & to put our unique collaboration in the picture! Antleron is proud to explore with Rousselot Biomedical the potential of X-Pure in regenerative medicine. Transforming healthcare and giving hope to patients:

    Poništi
  3. 9. sij

    . features 'Printing a Healthier Tomorrow' on 3D Systems / partnership. We envision to sustainably bring living therapies into the clinic together with 3D printing experts of .

    Poništi
  4. 3. sij

    Meet in our ‘Human behind the Scientist’ series. Started off as an intern, Jeroen is now researcher executing lab experiments related to dev. of cell-based products (, & ).

    Poništi
  5. 20. pro 2019.

    Warm season's greetings to all of you from the team! Let's continue to collaborate and innovate living therapies to increase health and comfort for all...

    Poništi
  6. 16. pro 2019.

    Feb 2020 => 2nd 'Life on Chip Conf - Enabling personalized medicine through cross-over innovation' in Leuven. co-organizes with , , , IBN Space 4.0, VIB , and

    Poništi
  7. 3. pro 2019.

    Thank you to invite to its Paris Summit (). 🥁 Excited to present the Antleron ideas in the Start-up Village & enjoy second event day. Looking forward to meet you at stand 41!

    Poništi
  8. 2. pro 2019.

    Present at Summit in Paris ()... to explore innovations that push healthcare boundaries. Tomorrow, will showcase (Stand 41) in start-up village. Welcome to visit & discuss.

    Poništi
  9. 29. stu 2019.

    Our CEO Jan Schrooten speaking at conference in Netherlands. Morning session, hosted by our partner , focused on innovative technologies and bringing from lab to patient.

    Poništi
  10. 22. stu 2019.

    The displayed part - printed on a 3D Systems MJP printer with VisiJet - facilitates engineering of advanced in closed system, eventually empowering patients with personalized, care.

    Poništi
  11. 20. stu 2019.

    Antleron’s 3D Printing & Processing Architect Simon Van Bael and CEO Jan Schrooten on booth at , demonstrating the unique capabilities of biocompatible .

    Poništi
  12. 19. stu 2019.

    Visit & at 2019 (Nov 19-21). "Excited to exhibit what's in store for next-generation applications with ProJet printers & VisiJet materials," says Jan Schrooten, CEO Antleron.

    Poništi
  13. 30. lis 2019.

    Evan Claes (Antleron) & Dominiek Rossillion () presented Cell by Design® at (CRIG) industrial partnering event. Find out more about Cell by Design®, the cloud-based process development facilitating software platform.

    Poništi
  14. 29. lis 2019.

    🎬 Watch the news headline on the partnership between & ... collaborating to accelerate biomedical breakthroughs

    Poništi
  15. 24. lis 2019.

    Thank you for your coverage!

    Poništi
  16. 24. lis 2019.

    Great coverage, !

    Poništi
  17. 24. lis 2019.
    Poništi
  18. 24. lis 2019.

    PRESS RELEASE Antleron has started a strategic partnership with => PERSBERICHT Antleron sluit een strategische bioprinting partnership af met 3D Systems =>

    Poništi
  19. 8. lis 2019.
    Poništi
  20. 1. lis 2019.

    Attend session of CEO Jan Schrooten on “Regenerative medicine valorisation strategies from ecosystem to SME” on Biomedica On The Move 2019 – Valorisation in in Geleen (NL).

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·